Analgesics in Switzerland

Analgesics in Switzerland

  • November 2021 •
  • 26 pages •
  • Report ID: 550600 •
  • Format: PDF
Minimal value sales growth was recorded in analgesics during 2021 and the category’s positive performance was largely the result of the easing of rationing that was seen during the year. The rationing in question refers to the limits that were placed on the amount of medications that Swiss people were allowed to buy at the peak of the COVID-19 pandemic.

Analgesics in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage:
Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact [email protected] if the problem remains.